A6.
TNMB stage system of Mycosis fungodies and Sézary syndrome
| Stage | Clinical manifestations |
| Skin | |
| T1 | Localized patches, papules, and/or plaques, <10% body surface area |
| T2 | Patches, papules, and/or plaques, ≥10% body surface area |
| T3 | One or more lumps are formed (diameter ≥1 cm) |
| T4 | Fusional erythema ≥80% body surface area |
| Lymph nodes | |
| N0 | No abnormal lymph nodes; no biopsy required |
| N1 | Abnormal lymph nodes; histopathology shows Dutch level 1 or NCI LN 0−2 |
| N2 | Abnormal lymph nodes; histopathology shows Dutch level 2 or NCI LN 3 |
| N3 | Abnormal lymph nodes; histopathology shows Dutch level 3−4 or NCI LN 4 |
| NX | Abnormal lymph nodes; no histological confirmation |
| Viscera | |
| M0 | No viscus involvement |
| M1 | Visceral involvement (required pathological diagnosis and indication of the affected organs) |
| MX | Visceral abnormalities; no histological diagnosis |
| Blood | |
| B0 | No obvious blood involvement: atypical cells (Sézary cells) accounts for 5% of peripheral blood lymphocytes |
| B1 | Low-load blood involvement: atypical cells (Sézary cells) accounts for >5% of peripheral blood lymphocytes, but do not reach B2 level |
| B2 | High-load blood involvement: atypical cells (Sézary cells) ≥1,000/μL or CD4+/CD7− cell ratio ≥40% or CD4+/CD26− cell ratio ≥30% |